The gap

A supply chain that forgets the patient

Every actor in the chain, manufacturer, distributor, pharmacy, regulator, holds one fragment of the truth about a pack of medicine. None of them hold the patient's fragment. That is the gap RxLoop closes.

A falsified pack looks like medicine, costs like medicine, and is sold by someone who believes it is medicine. The failure is not one bad actor, it is that nobody downstream can check, and when something goes wrong there is no route for that signal to travel back up.

1 in 10

medical products in low- and middle-income countries are substandard or falsified.

WHO 2017. Verify against the blueprint before publishing.

42%
of substandard and falsified reports to WHO's global surveillance system come from the African region.
~$30B
estimated annual spend on substandard and falsified medicines across low- and middle-income countries.
64–158K
estimated deaths each year in Sub-Saharan Africa linked to poor-quality antimalarials.

The patient is the only person who touches every pack, and the only one with no way to check it.

RxLoop is a middleware layer between people and the medicines they already hold. It does three things: gives reference guidance a person can read in their own language, captures a report when a pack looks wrong, and keeps a full course on schedule until it is finished. All of it runs offline, because the places where falsified medicine circulates are the same places where data does not.

Next

Reference